Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Works by Le-Tian Huang
Results: 23
1
2
Untargeted lipidomic analysis and network pharmacology for parthenolide treated papillary thyroid carcinoma cells.
- Published in:
- BMC Complementary Medicine & Therapies, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12906-023-03944-7
- By:
- Publication type:
- Article
3
Parthenolide leads to proteomic differences in thyroid cancer cells and promotes apoptosis.
- Published in:
- BMC Complementary Medicine & Therapies, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12906-022-03579-0
- By:
- Publication type:
- Article
4
Inaudible Sound Covert Channel with Anti-Jamming Capability: Attacks vs. Countermeasure.
- Published in:
- Journal of Electronic Science & Technology, 2022, v. 20, n. 4, p. 396, doi. 10.1016/j.jnlest.2022.100181
- By:
- Publication type:
- Article
5
Efficacy and safety of recombinant human endostatin combined with radiotherapy or chemoradiotherapy in patients with locally advanced non-small cell lung cancer: a pooled analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
6
Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: a systematic review and meta-analysis of 11 randomized controlled trials.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11194-6
- By:
- Publication type:
- Article
7
Retraction Note to: The Influence of mtDNA Deletion on Lung Cancer Cells Under the Conditions of Hypoxia and Irradiation.
- Published in:
- 2015
- By:
- Publication type:
- Erratum
8
The Influence of mtDNA Deletion on Lung Cancer Cells Under the Conditions of Hypoxia and Irradiation.
- Published in:
- Lung (0341-2040), 2014, v. 192, n. 6, p. 997, doi. 10.1007/s00408-014-9639-9
- By:
- Publication type:
- Article
9
Efficacy and safety of combined immunotherapy and antiangiogenesis with or without chemotherapy for advanced non-small-cell lung cancer: A systematic review and pooled analysis from 23 prospective studies.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.920165
- By:
- Publication type:
- Article
10
Durable Clinical Response to Pyrotinib After Resistance to Prior Anti-HER2 Therapy for HER2-Positive Advanced Gastric Cancer: A Case Report.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01453
- By:
- Publication type:
- Article
11
The Optimal First‐Line Therapy for Extensive‐Stage Small‐Cell Lung Cancer Based on Liver Metastasis Status: A Network Meta‐Analysis and Systematic Review.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 18, p. 1, doi. 10.1002/cam4.70256
- By:
- Publication type:
- Article
12
Rational application of the first‐line chemotherapy and immune checkpoint inhibitors in advanced nonsmall cell lung cancer: A meta‐analysis.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 11, p. 5033, doi. 10.1002/cam4.2407
- By:
- Publication type:
- Article
13
A clinical study on the treatment of postherpetic neuralgia with pulsed radiofrequency of the dorsal root ganglion with pain management.
- Published in:
- Neurology Asia, 2020, v. 25, n. 3, p. 313
- By:
- Publication type:
- Article
14
Rational Application of First-Line EGFR-TKIs Combined with Antiangiogenic Inhibitors in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/8850256
- By:
- Publication type:
- Article
15
Association of Peripheral Blood Cell Profile With Alzheimer's Disease: A Meta-Analysis.
- Published in:
- Frontiers in Aging Neuroscience, 2022, v. 14, p. 1, doi. 10.3389/fnagi.2022.888946
- By:
- Publication type:
- Article
16
A state-of-the-art review of functional magnetic resonance imaging technique integrated with advanced statistical modeling and machine learning for primary headache diagnosis.
- Published in:
- Frontiers in Human Neuroscience, 2023, p. 01, doi. 10.3389/fnhum.2023.1256415
- By:
- Publication type:
- Article
17
Clinical option of pemetrexed-based versus paclitaxel-based first-line chemotherapeutic regimens in combination with bevacizumab for advanced non-squamous non-small-cell lung cancer and optimal maintenance therapy: evidence from a meta-analysis of randomized control trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
18
Short-term outcomes and safety of radiotherapy for immediate breast reconstruction with autologous flap transfer following breast-conserving surgery.
- Published in:
- 2021
- By:
- Publication type:
- journal article
19
Targeting mitochondria: restoring the antitumor efficacy of exhausted T cells.
- Published in:
- Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-02175-9
- By:
- Publication type:
- Article
20
Prognostic and clinicopathologic significance of PLIN2 in cancers: A systematic review with meta-analysis.
- Published in:
- International Journal of Biological Markers, 2023, v. 38, n. 1, p. 3, doi. 10.1177/03936155221147536
- By:
- Publication type:
- Article
21
Efficacy of Osimertinib in EGFR-Mutated Advanced Non-small-Cell Lung Cancer With Different T790M Status Following Resistance to Prior EGFR-TKIs: A Systematic Review and Meta-analysis.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.863666
- By:
- Publication type:
- Article
22
Insights Into the Role of Platelet-Derived Growth Factors: Implications for Parkinson's Disease Pathogenesis and Treatment.
- Published in:
- Frontiers in Aging Neuroscience, 2022, v. 14, p. 1, doi. 10.3389/fnagi.2022.890509
- By:
- Publication type:
- Article
23
Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC: A Systematic Review and Pooled Analysis of Five Prospective Clinical Trials.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.586596
- By:
- Publication type:
- Article